A multicenter, randomized, open-label, phase 3 trial (AcceleRET-MTC) has recently begun to compare pralsetinib with cabozantinib or vandetanib in patients without prior multi-kinase inhibitor therapy in RET -mutant MTC (NCT04760288)
These include CMA, aggrephagy (selective autophagy of protein aggregates), and lysosomal degradation pathways
This was a massive amount of structures, and all the things that you don't know that are in there burning with the power of the wind behind it," said Marquez
Does GLP-1 Increase Resting Heart Rate
Both Wegovy and alcohol can influence your metabolism and blood sugar levels, leading to unpredictable outcomes
Supplement guidance is included when evidence supports a role in metabolic health and blood sugar management